SCHEMBL3704070

SCHEMBL3704070

NC(=O)C(c1ccccc1)C(O)O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.56
LMNA P02545 3/20 0.48
CES2 O00748 2/20 0.48
CES1 P23141 2/20 0.48
MAPK1 P28482 1/20 0.48
EPHX1 P07099 1/20 0.47
KMT2A Q03164 1/20 0.47
BCAT2 O15382 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SRC P12931 1/20 0.44
CYP1A2 P05177 1/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALOX5 P09917 1/20 0.42
CTSD P07339 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31242992 0.88 CYP2D6 (0.64) CYP2D6LMNACES2CES1MAPK1
SCHEMBL8444103 0.83 CYP2D6 (0.52) CYP2D6LMNAMAPK1EPHX1KMT2A
SCHEMBL11022438 0.82 CYP2D6 (0.56) CYP2D6LMNACES2CES1MAPK1
SCHEMBL21939337 0.81 CYP2D6 (0.76) CYP2D6LMNACES2CES1MAPK1
SCHEMBL5475337 0.80 CYP2D6 (0.54) CYP2D6LMNAEPHX1KMT2AALOX5
SCHEMBL14749339 0.80 CYP2D6 (0.54) CYP2D6LMNAEPHX1KMT2AALOX5
SCHEMBL11022387 0.80 CYP2D6 (0.54) CYP2D6LMNACES2CES1MAPK1
SCHEMBL1483328 0.80 CYP2D6 (0.54) CYP2D6LMNAEPHX1KMT2AALOX5
SCHEMBL21327667 0.78 CYP2D6 (0.52) CYP2D6LMNAEPHX1KMT2ASRC
SCHEMBL8376271 0.78 CYP2D6 (0.52) CYP2D6LMNAEPHX1KMT2ASRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996008487-A1 ENDOTHELIN ANTAGONISTS BEARING PYRIDYL AMIDES MERCK & CO., INC. (US) 1996-03-21 WO claimed
WO-1996008486-A1 ENDOTHELIN ANTAGONISTS BEARING 5-MEMBERED HETEROCYCLIC AMIDES MERCK & CO., INC. (US) 1996-03-21 WO claimed
EP-2396003-A2 A COMPOSITION COMPRISING (-)-TRANS-3-(5,6-DIHYDRO-4H-PYRROLO [3,2,1-IJ] QUINOLIN-1-YL)-4-(1H-INDOL-3-YL) PYRROLIDINE-2, 5-DIONE IN COMBINATION WITH A SECOND ANTI-PROLIFERATIVE AGENT, ArQule, Inc. (US) 2011-12-21 EP disclosed
WO-2010093789-A2 COMBINATIONAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER ARQULE, INC. (US) 2010-08-19 WO disclosed
EP-1846406-A1 MALEIMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER ArQule, Inc. (US) 2007-10-24 EP disclosed
WO-2006086484-A1 MELEIMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER ARQULE, INC. (US) 2006-08-17 WO disclosed
WO-1996008486-A1 ENDOTHELIN ANTAGONISTS BEARING 5-MEMBERED HETEROCYCLIC AMIDES MERCK & CO., INC. (US) 1996-03-21 WO disclosed